Literature DB >> 3322024

Interleukin I and the glomerular mesangium. II. Monokine stimulation of mesangial cell prostanoid secretion.

D H Lovett1, K Resch, D Gemsa.   

Abstract

Monocytic (MC) infiltration is a prominent feature of many forms of immune-mediated glomerulonephritis. Through the release of interleukin-1, (IL-1), monocyte/macrophages have been shown to induce the proliferation of mesangial cells and to stimulate the secretion of a glomerular basement membrane-degrading neutral proteinase. In addition, mesangial cells release a cytokine that expresses many of the biologic properties of monocyte IL-1, including stimulation of mesangial cell proliferation. Because many of the actions of IL-1 are mediated by the induction of prostanoid prostaglandin (PG) synthesis, the authors determined the effects of purified macrophage and mesangial IL-1 on the secretion of prostaglandin E (PGE), prostacyclin, and thromboxane. The results indicated that cycling MCs release primarily PGE in response to purified IL-1. The local release by either monocytes or mesangial cells of IL-1 during glomerular inflammation, with subsequent mesangial cell generation of vasodilatory PGE, may be responsible in part for the alterations in the glomerular microcirculation observed in these disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322024      PMCID: PMC1899818     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum.

Authors:  W Grimm; M Seitz; H Kirchner; D Gemsa
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

2.  The temporal relationship between glomerular cell proliferation and monocyte infiltration in experimental glomerulonephritis.

Authors:  R B Sterzel; R Pabst
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1982

3.  Human glomerular cells in vitro: isolation and characterization.

Authors:  G E Striker; P D Killen; F M Farin
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

4.  Ability of human leukocytic pyrogen to stimulate brain prostaglandin synthesis in vitro.

Authors:  C A Dinarello; H A Bernheim
Journal:  J Neurochem       Date:  1981-09       Impact factor: 5.372

5.  Production of lymphocyte activating factor in the absence of endogenous pyrogen by rabbit or human leukocytes stimulated by a muramyl dipeptide derivative.

Authors:  C Damais; G Riveau; M Parant; J Gerota; L Chedid
Journal:  Int J Immunopharmacol       Date:  1982

6.  Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells.

Authors:  T Okegawa; P E Jonas; K DeSchryver; A Kawasaki; P Needleman
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

7.  Proliferative glomerulonephritis in rats: evidence that mononuclear phagocytes infiltrating the glomeruli stimulate the proliferation of endothelial and mesangial cells.

Authors:  C H Dubois; J B Foidart; M B Hautier; C A Dechenne; M J Lemaire; P R Mahieu
Journal:  Eur J Clin Invest       Date:  1981-04       Impact factor: 4.686

8.  Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.

Authors:  C A Dinarello; S O Marnoy; L J Rosenwasser
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  A mononuclear cell component in experimental immunological glomerulonephritis.

Authors:  G F Schreiner; R S Cotran; V Pardo; E R Unanue
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  8 in total

1.  Transforming growth factor beta 2 differentially modulates interleukin-1 beta- and tumour-necrosis-factor-alpha-stimulated phospholipase A2 and prostaglandin E2 synthesis in rat renal mesangial cells.

Authors:  J Pfeilschifter; W Pignat; J Leighton; F Märki; K Vosbeck; S Alkan
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

2.  Activation of glomerular mesangial cells by gram-negative bacterial cell wall components.

Authors:  D H Lovett; S L Bursten; D Gemsa; W Bessler; K Resch; J L Ryan
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

3.  Induction of ecto-5'-nucleotidase of rat cultured mesangial cells by interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  V Savic; V Stefanovic; N Ardaillou; R Ardaillou
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

4.  Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells.

Authors:  J Pfeilschifter; J Leighton; W Pignat; F Märki; K Vosbeck
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

5.  Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.

Authors:  J Floege; N Topley; J Hoppe; T B Barrett; K Resch
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Lipid A stimulates phospholipase D activity in rat mesangial cells via a G-protein.

Authors:  W E Harrris; S L Bursten
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

Review 7.  The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system.

Authors:  H H Radeke; K Resch
Journal:  Clin Investig       Date:  1992-09

8.  Activated T-lymphocytes induce growth inhibition and prostaglandin E2 release from syngeneic glomerular mesangial cells.

Authors:  H H Radeke; B Schwinzer; K Resch
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.